𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modeling the interaction between the N-terminal domain of the tumor suppressor p53 and azurin

✍ Scribed by Monia Taranta; Anna Rita Bizzarri; Salvatore Cannistraro


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
395 KB
Volume
22
Category
Article
ISSN
0952-3499

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

It is known that the half life of the tumor suppressor p53 can be increased by the interaction with the bacterial protein azurin, resulting in an enhanced anti‐tumoral activity. The understanding of the molecular mechanisms on the basis of this phenomenon can open the way to new anti‐cancer strategies. Some experimental works have given evidence of an interaction between p53 and azurin (AZ); however the binding regions of the proteins are still unknown. Recently, fluorescence studies have shown that p53 partakes in the binding with the bacterial protein by its N‐terminal (NT) domain. Here we have used a computational method to get insight into this interacting mode. The model that we propose for the best complex between AZ and p53 has been obtained from a rigid‐body docking, coupled with a molecular dynamics (MD) simulation, a free energy calculation, and validated by mutagenesis analysis. We have found a high degree of geometric fit between the two proteins that are kept together by several hydrophobic interactions and numerous hydrogen bonds. Interestingly, it has emerged that AZ binds essentially to the helices H~I~ and H~III~ of the p53 NT domain, which are also interacting regions for the foremost inhibitor of p53, MDM2. Copyright Β© 2009 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Probing the interaction between p53 and
✍ Monia Taranta; Anna Rita Bizzarri; Salvatore Cannistraro πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 415 KB

## Abstract p53 is a human tumour suppressor which regulates multiple cellular processes, including cell growth, genomic stability and cell death. Recent works have demonstrated the bacterial redox protein azurin to enter cancer cells and induce apoptosis through p53 stabilization, resulting in a t

Interaction between the pRb2/p130 C-term
✍ Francesco Bonetto; Maurizio Fanciulli; Tullio Battista; Antonio De Luca; Patrizi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 222 KB πŸ‘ 1 views

An association between cyclin D3 and the C-terminal domain of pRb2/p130 was demonstrated using the yeast two-hybrid system. Further analysis restricted the epitope responsible for the binding within the 74 N-terminal amino acids of cyclin D3, independent of the LXCXE amino acid motif present in the

Cellular and organismal ageing: Role of
✍ Gerald Schmid; Matthias P. Kramer; Margarita Maurer; Stefanie Wandl; JΓ³zefa WΔ™si πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 258 KB

## Abstract In recent years, an impact of the p53 tumor suppressor protein in the processes of cellular and organismal ageing became evident. First hints were found in model organisms like __Saccharomyces cerevisiae__, __Caenorhabditis elegans__, and __Drosophila melanogaster__ where a clear connec

How the other half lives, the amino-term
✍ David W. Goodrich πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 211 KB

## Abstract The retinoblastoma tumor suppressor gene (__RB1__) is currently the only known gene whose mutation is necessary and sufficient for the development of a human cancer. Mutation or deregulation of RB1 is observed so frequently in other tumor types that compromising RB1 function may be a pr

Using peptides to study the interaction
✍ Ronen Gabizon; Michal Mor; Masha M. Rosenberg; Lena Britan; Zvi Hayouka; Moshe K πŸ“‚ Article πŸ“… 2008 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 367 KB

## Abstract Peptides are valuable tools for studying protein–protein interactions, especially in cases of isolated protein domains and natively unfolded proteins. Here, we used peptides to quantitatively characterize the interaction between the natively unfolded HIV‐1 Tat protein and the tetrameriz

Pharmacogenomics of the p53 tumor suppre
✍ Suxing Liu; W. Robert Bishop; Bimal Dasmahapatra; Yaolin Wang πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 1 views

## Abstract Drug resistance remains a key obstacle to successful cancer treatment. The implementation of pharmacogenomics is widely proclaimed as a route to revolutionize the face of cancer therapy. Here we discuss the pharmacogenomics of the p53 tumor suppressor and its role in cancer chemosensiti